Yao, K., Goldschmidt, R., Turk, M., Wesseling, J., Stork-Sloots, L., de Snoo, F., & Cristofanilli, M. (2015). Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups. Breast Cancer Res Treat.
Citación estilo ChicagoYao, Katharine, Robert Goldschmidt, Mary Turk, Jelle Wesseling, Lisette Stork-Sloots, Femke de Snoo, and Massimo Cristofanilli. "Molecular Subtyping Improves Diagnostic Stratification of Patients With Primary Breast Cancer Into Prognostically Defined Risk Groups." Breast Cancer Res Treat 2015.
Cita MLAYao, Katharine, et al. "Molecular Subtyping Improves Diagnostic Stratification of Patients With Primary Breast Cancer Into Prognostically Defined Risk Groups." Breast Cancer Res Treat 2015.